PSTV Historical PE Ratio image   This PSTV PE ratio history page last updated 10/24/2022
PSTV Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2022
10/20/2022
0.48-0.19-0.76NA
Q2 2022
7/21/2022
0.51-0.24-0.96NA
Q1 2022
4/21/2022
0.88-0.19-0.76NA
Q4 2021
2/24/2022
1.01-0.27-1.08NA
Q3 2021
10/21/2021
1.73-0.28-1.12NA
Q2 2021
7/22/2021
2.28-0.25-1.00NA
Q1 2021
4/22/2021
2.24-0.33-1.32NA
Q4 2020
2/22/2021
3.75-0.74-2.96NA
Q3 2020
10/22/2020
2.76-0.39-1.56NA
Q2 2020
8/10/2020
2.99-0.45-1.80NA
Q1 2020
5/14/2020
2.13-0.28-1.12NA
Q4 2019
3/30/2020
2.270.662.640.9
Q3 2019
11/14/2019
2.39-0.03-0.12NA
Q2 2019
8/15/2019
3.88-5.12-20.48NA
Q1 2019
5/14/2019
13.00-0.18-0.72NA
Q4 2018
3/29/2019
13.000.110.4429.5
Q3 2018
11/14/2018
17.00-0.45-1.80NA
Q2 2018
8/14/2018
20.00-0.59-2.36NA
Q1 2018
5/10/2018
16.00-0.07-0.28NA
Q4 2017
3/8/2018
16.00-0.10-0.40NA
Q3 2017
11/9/2017
20.00-0.14-0.56NA
Q2 2017
8/10/2017
17.50-0.19-0.76NA
Q1 2017
5/11/2017
47.00-0.26-1.04NA
Q4 2016
3/23/2017
82.00-0.24-0.96NA
Q3 2016
11/9/2016
86.00-0.26-1.04NA
Q2 2016
8/4/2016
109.00-0.43-1.72NA
Q1 2016
5/10/2016
13.50-0.03-0.12NA
Q4 2015
3/3/2016
10.50-0.03-0.12NA
Q3 2015
11/5/2015
19.00-0.04-0.16NA
Q2 2015
8/6/2015
20.50-0.06-0.24NA
Q1 2015
5/11/2015
35.50-0.07-0.28NA
Q4 2014
3/12/2015
57.50-0.08-0.32NA
Q3 2014
11/6/2014
25.00-0.12-0.48NA
Q2 2014
8/11/2014
84.50-0.15-0.60NA
Q1 2014
5/12/2014
124.50-0.14-0.56NA
Q4 2013
3/11/2014
153.50-0.14-0.56NA
Q3 2013
11/7/2013
139.00-0.08-0.32NA
Q2 2013
8/8/2013
132.500.050.20>500
Q1 2013
5/9/2013
129.50-0.11-0.44NA
Q4 2012
3/7/2013
146.50-0.55-2.20NA
Q3 2012
11/8/2012
161.00-0.19-0.76NA
Q2 2012
8/8/2012
121.50-0.13-0.52NA
PSTV PE History Chart
PeriodPriceGAAPTTMPE
Q3 2022
10/20/2022
0.48-0.19-0.89NA
Q2 2022
7/21/2022
0.51-0.24-0.98NA
Q1 2022
4/21/2022
0.88-0.19-0.99NA
Q4 2021
2/24/2022
1.01-0.27-1.13NA
Q3 2021
10/21/2021
1.73-0.28-1.60NA
Q2 2021
7/22/2021
2.28-0.25-1.71NA
Q1 2021
4/22/2021
2.24-0.33-1.91NA
Q4 2020
2/22/2021
3.75-0.74-1.86NA
Q3 2020
10/22/2020
2.76-0.39-0.46NA
Q2 2020
8/10/2020
2.99-0.45-0.10NA
Q1 2020
5/14/2020
2.13-0.28-4.77NA
Q4 2019
3/30/2020
2.270.66-4.67NA
Q3 2019
11/14/2019
2.39-0.03-5.22NA
Q2 2019
8/15/2019
3.88-5.12-5.64NA
Q1 2019
5/14/2019
13.00-0.18-1.11NA
Q4 2018
3/29/2019
13.000.11-1.00NA
Q3 2018
11/14/2018
17.00-0.45-1.21NA
Q2 2018
8/14/2018
20.00-0.59-0.90NA
Q1 2018
5/10/2018
16.00-0.07-0.50NA
Q4 2017
3/8/2018
16.00-0.10-0.69NA
Q3 2017
11/9/2017
20.00-0.14-0.83NA
Q2 2017
8/10/2017
17.50-0.19-0.95NA
Q1 2017
5/11/2017
47.00-0.26-1.19NA
Q4 2016
3/23/2017
82.00-0.24-0.96NA
Q3 2016
11/9/2016
86.00-0.26-0.75NA
Q2 2016
8/4/2016
109.00-0.43-0.53NA
Q1 2016
5/10/2016
13.50-0.03-0.16NA
Q4 2015
3/3/2016
10.50-0.03-0.20NA
Q3 2015
11/5/2015
19.00-0.04-0.25NA
Q2 2015
8/6/2015
20.50-0.06-0.33NA
Q1 2015
5/11/2015
35.50-0.07-0.42NA
Q4 2014
3/12/2015
57.50-0.08-0.49NA
Q3 2014
11/6/2014
25.00-0.12-0.55NA
Q2 2014
8/11/2014
84.50-0.15-0.51NA
Q1 2014
5/12/2014
124.50-0.14-0.31NA
Q4 2013
3/11/2014
153.50-0.14-0.28NA
Q3 2013
11/7/2013
139.00-0.08-0.69NA
Q2 2013
8/8/2013
132.500.05-0.80NA
Q1 2013
5/9/2013
129.50-0.11-0.98NA
Q4 2012
3/7/2013
146.50-0.55NANA
Q3 2012
11/8/2012
161.00-0.19NANA
Q2 2012
8/8/2012
121.50-0.13NANA
Quotes delayed 20 minutes

Email EnvelopeFree PSTV Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Plus Therapeutics (PSTV) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

PSTX PE Ratio History
PTCT PE Ratio History
PTE PE Ratio History
PTGX PE Ratio History
PTIX PE Ratio History
PTPI PE Ratio History
PULM PE Ratio History
QDEL PE Ratio History
QLGN PE Ratio History
QNCX PE Ratio History
How should the PSTV historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Plus Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this PSTV Historical PE Ratio page.

What is the average historical PE for PSTV based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The PSTV historical PE ratio using the annualized quarterly earnings method works out to 15.2.

What is the average historical PE for PSTV based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The PSTV historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the PSTV Historical PE Ratio information for Plus Therapeutics' stock. The average PSTV historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 15.2. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average PSTV historical PE based on this TTM earnings result method is NA. Note: any PE calculations resulting in a value exceeding 500 were discarded as not meaningful. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this PSTV historical PE result, against the recent PE: when this page was posted on 10/21/2022, the most recent closing price for PSTV had been 0.47, and the most recent quarterly earnings result, annualized, was 2.64. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent PSTV PE on 10/21/2022 based on annualized quarterly EPS was 0.2. Based on PSTV's history, that recent PE is low relative to the historical average, with the recent PE 98.7% lower than the historical average PE across our data set for Plus Therapeutics.

For self directed investors doing their due diligence on PSTV or any other given stock, valuation analysis for PSTV can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Plus Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for PSTV. Thanks for visiting, and the next time you need to research PSTV Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Funds Holding QIHU, Institutional Holders of MNBD, AMWL Historical Stock Prices.

 

PSTV Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.